The present invention relates to the use of pteridine derivatives as nitric oxide synthase activators. In particular, the derivatives find use in the treatment of diseases associated with endothelial dysfunction such as cardiovascular diseases.
|Patent number||US 2006/0194800 A1|
|Publication status||Published - 2005|
- cardiovascular disease
- endothelial dysfunction